Fremanezumab in Participants With Posttraumatic Headache (PTH)

Study Title
A Study to Test if Fremanezumab Reduces Headache in Patients With Posttraumatic Headache (PTH)
Teva Identifier
TV48125-CNS-20024
ClinicalTrials.gov Identifier
NCT03347188
Study Status
Completed
Trial Condition(s)
Post-Traumatic Headache
Interventions
Drug: Fremanezumab | Drug: Placebo

Study Description

Please refer to ClinicalTrials.gov for a description of the trial
Print

Click for participation criteria and map of study locations


Key Participation Requirements

Gender
Female, Male
Age Range
18 Years to 70 Years
Trial Duration
November 17, 2017 - June 3, 2020
Phase
Phase 2

Study Type

Interventional